Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial by Goldberg, Sarah B, MD, Schalper, Kurt A, MD, Gettinger, Scott N, Prof, Mahajan, Amit, MD, Herbst, Roy S, Prof, Chiang, Anne C, MD, Lilenbaum, Rogerio, Prof, Wilson, Frederick H, MD, Omay, Sacit Bulent, MD, Yu, James B, Prof, Jilaveanu, Lucia, PhD, Tran, Thuy, MD, Pavlik, Kira, MPH, Rowen, Elin, MSN, Gerrish, Heather, BSN, Komlo, Annette, MBA, Gupta, Richa, BS, Wyatt, Hailey, BS, Ribeiro, Matthew, BS, Kluger, Yuval, Prof, Zhou, Geyu, BSc, Wei, Wei, PhD, Chiang, Veronica L, Prof, Kluger, Harriet M, Prof

Get full text

Understanding the Impact of Population and Cancer Type on Tumor Mutation Burden Scores: A Comprehensive Whole-Exome Study in Cancer Patients From India by Tanwar, Nishtha AjitSingh, Malhotra, Richa, Satheesh, Aiswarya Padmaja, Khuntia, Satya Prakash, Sreekanthreddy, Peddagangannagari, Varghese, Linu, Kolla, Srivalli, Chandrani, Pratik, Choughule, Anuradha, Pange, Priyanka, Gupta, Vinod, Noronha, Vanita, Patil, Vijay Maruti, Pramanik, Raja, Kumar, Sunila, Nayak, Sandeep Peraje, Babu, Suresh, Shetty, Rohan, Kantharaju, Madan, Chinder, Pramod Shekarappa, Korlimarla, Aruna, Srinath, B S, Prabhash, Kumar, Rishi, Kshitij Datta, Goswami, Hitesh Madan, Veldore, Vidya Harini

Get full text